The adenine nucleotide translocator: regulation and function during myocardial development and hypertrophy
- PMID: 11985546
- DOI: 10.1046/j.1440-1681.2002.03654.x
The adenine nucleotide translocator: regulation and function during myocardial development and hypertrophy
Abstract
1. The present review focuses on the adenine nucleotide translocator (ANT), which facilitates exchange of cytosolic ADP for mitochondrial ATP. This protein serves a central role in regulating cellular oxidative capacity. 2. The ANT, a nuclear-encoded mitochondrial protein, is developmentally regulated and, thus, accumulates within the mitochondrial membrane during maturation. 3. Accumulation of ANT parallels changes in kinetics of myocardial respiration determined from 31P magnetic resonance spectroscopy studies. 4. Thyroid hormone modulates developmental transitions in ANT content, as well as respiratory control patterns. These transitions are linked to quantitative ANT changes, not to alterations in functionality at individual exchanger sites. 5. Developmental programming for ANT and parallel alterations in oxidative phosphorylation kinetics are relevant to the heart, which exhibits remodelling in response to pathological processes. Maladaptive hearts exhibiting ANT deficits demonstrate ADP-dependent respiratory kinetics similar to the newborn heart. Thus, ANT deficits and alterations in mitochondrial respiratory function may contribute to the pathogenesis of myocardial remodelling and heart failure.
Similar articles
-
Expression of adenine nucleotide translocator parallels maturation of respiratory control in heart in vivo.Am J Physiol. 1997 Oct;273(4):H1977-83. doi: 10.1152/ajpheart.1997.273.4.H1977. Am J Physiol. 1997. PMID: 9362269
-
Thyroid hormone coordinates respiratory control maturation and adenine nucleotide translocator expression in heart in vivo.Circulation. 2000 Sep 12;102(11):1323-9. doi: 10.1161/01.cir.102.11.1323. Circulation. 2000. PMID: 10982550
-
Maturational changes in gene expression for adenine nucleotide translocator isoforms and betaF1-ATPase in rabbit heart.Mol Genet Metab. 1999 Feb;66(2):75-9. doi: 10.1006/mgme.1998.2793. Mol Genet Metab. 1999. PMID: 10068509
-
Adenine nucleotide translocase in the focus of cardiovascular diseases.Trends Cardiovasc Med. 2007 Nov;17(8):284-90. doi: 10.1016/j.tcm.2007.10.001. Trends Cardiovasc Med. 2007. PMID: 18021939 Review.
-
Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator.Cell Death Differ. 2000 Dec;7(12):1146-54. doi: 10.1038/sj.cdd.4400778. Cell Death Differ. 2000. PMID: 11175251 Review.
Cited by
-
Downregulation of adenine nucleotide translocator 1 exacerbates tumor necrosis factor-α-mediated cardiac inflammatory responses.Am J Physiol Heart Circ Physiol. 2015 Jan 1;308(1):H39-48. doi: 10.1152/ajpheart.00330.2014. Epub 2014 Nov 7. Am J Physiol Heart Circ Physiol. 2015. PMID: 25380814 Free PMC article.
-
Developmental restructuring of the creatine kinase system integrates mitochondrial energetics with stem cell cardiogenesis.Ann N Y Acad Sci. 2008 Dec;1147:254-63. doi: 10.1196/annals.1427.004. Ann N Y Acad Sci. 2008. PMID: 19076447 Free PMC article.
-
Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy.Genomics. 2009 Jul;94(1):20-31. doi: 10.1016/j.ygeno.2009.03.003. Epub 2009 Mar 28. Genomics. 2009. PMID: 19332114 Free PMC article.
-
Adenine nucleotide translocase 1 deficiency results in dilated cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and activation of apoptosis.JACC Cardiovasc Imaging. 2011 Jan;4(1):1-10. doi: 10.1016/j.jcmg.2010.06.018. JACC Cardiovasc Imaging. 2011. PMID: 21232697 Free PMC article.
-
Bioenergetic remodeling of heart mitochondria by thyroid hormone.Mol Cell Biochem. 2004 Oct;265(1-2):97-106. doi: 10.1023/b:mcbi.0000044321.17680.a2. Mol Cell Biochem. 2004. PMID: 15543939
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources